Spondylodiscitis
Conditions
Keywords
discitis, Spondylitis, Spine surgery
Brief summary
To evaluate the long term outcomes of patients with thoracolumbar spondylodiscitis treated surgically by posterior approach. Outcomes include bony fusion, neurological improvement, pain improvement, implant related complication, recurrence of infection and or reoperation rate
Detailed description
spondylodiscitis is characterized by infection that primarily affects the intervertebral disc and adjacent vertebrae. The estimated incidence of spondylodiscitis, ranging from 0.2 to 10 per 100,000 inhabitants per year, has increased in recent years, which is likely associated with an aging population, higher prevalence of chronic disease, and more effective diagnostic techniques. Spondylodiscitis is a life-threatening disease with a mortality rate of 2-20% that is often associated with potential complications, such as paraspinal abscess, epidural abscess, meningitis, spinal instability, and neurologic deficiency. The relapse rates were reported to be as high as 32% in the literature. The aims of this study are to evaluate improvements, complications, recurrence and reoperation rates in Assiut university hospitals.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* • All patients had thoracolumbar spondylodiscitis from number 1 thoracic vertebra till number 1 sacral vertebra. * Treated surgically by posterior approach only.
Exclusion criteria
* • Patients with incomplete follow up. * Multifocal discitis.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bony fusion success | 2 years | the degree of bridging bone across the fused vertebral bodies by using x-ray, CT scan and MRI if needed |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| modified Oswestry disability index | 2 years | for patient quality of life postoperative |
| visual analogue scale | 2years | the amount of pain sensed by the patient pre and post-operative |
| American spinal injury Association (ASIA) Impairment score | 2 years | to asses neurological outcomes pre operative and at 2 years follow up. |